2014

Aging and Heart Failure

Mechanisms and Management

Editors:

ISBN: 978-1-4939-0267-5 (Print) 978-1-4939-0268-2 (Online)

Table of contents (32 chapters)

previous Page of 2
  1. Front Matter

    Pages i-xxii

  2. No Access

    Book Chapter

    Pages 1-14

    Changing Demographics of the Aging Population with Heart Failure and Implications for Therapy

  3. No Access

    Book Chapter

    Pages 15-33

    Biology of Aging and Implications for Heart Failure Therapy and Prevention

  4. No Access

    Book Chapter

    Pages 35-45

    Hypertension and Prevention of Diastolic Heart Failure in the Aging Population

  5. No Access

    Book Chapter

    Pages 47-63

    Aging and Optimal Therapy of Systolic Heart Failure in the Elderly

  6. No Access

    Book Chapter

    Pages 65-84

    Atrial Fibrillation and Heart Failure in the Aging Population

  7. No Access

    Book Chapter

    Pages 85-93

    Optimizing Therapy of Heart Failure in the Aging Population with Monitoring in Clinics

  8. No Access

    Book Chapter

    Pages 95-106

    Cardiac Alterations in Aging, Hypertension, and Diastolic Heart Failure

  9. No Access

    Book Chapter

    Pages 107-116

    Polypharmacy and Adverse Drug Reactions in the Aging Population with Heart Failure

  10. No Access

    Book Chapter

    Pages 117-134

    Age-Related Changes in Vascular Biology and Implications for Heart Failure Therapy in the Aging Population

  11. No Access

    Book Chapter

    Pages 135-146

    Biomarkers and Optimal Management of Heart Failure in the Aging Population

  12. No Access

    Book Chapter

    Pages 147-164

    Benefits of Exercise in the Elderly

  13. No Access

    Book Chapter

    Pages 165-182

    The RAAS in Heart Failure: An Update on Clinical Trials and Opportunities for Therapy

  14. No Access

    Book Chapter

    Pages 183-198

    Aging and Diastolic Dysfunction: The Interplay of Inflammation and Extracellular Matrix Regulation

  15. No Access

    Book Chapter

    Pages 199-220

    Reperfusion and Vasodilator Therapy in Elderly Patients with STEMI and Heart Failure: Improving Outcomes

  16. No Access

    Book Chapter

    Pages 221-241

    Erythropoietin Therapy for Heart Failure

  17. No Access

    Book Chapter

    Pages 243-247

    Role of Resistin in Heart Failure in the Elderly

  18. No Access

    Book Chapter

    Pages 249-257

    Role of Coronary Artery Calcium in Cardiovascular Risk Stratification and Management in the Aging Population

  19. No Access

    Book Chapter

    Pages 259-289

    Aging and Remodeling of the RAS and RAAS and Related Pathways: Implications for Heart Failure Therapy

  20. No Access

    Book Chapter

    Pages 291-304

    Aging and Right Ventricular Failure from Pulmonary Hypertension: Effect of Right Ventricular and Pulmonary Artery Remodeling

  21. No Access

    Book Chapter

    Pages 305-318

    Biomarkers of Cardiovascular Aging

previous Page of 2